https://orcid.org/0000-0003-1082-5674
References
- Uhre M-L, Gotland N, Sandholdt H, et al. Increased risk of diabetes mellitus five years after an episode of Staphylococcus aureus bacteraemia. Infect Dis. 2019;51(7):512–518.
- Stacey HJ, Clements CS, Welburn SC, et al. The prevalence of methicillin-resistant Staphylococcus aureus among diabetic patients: a meta-analysis. Acta Diabetol. 2019;56(8):907–921.
- Ellis MW, Griffith ME, Jorgensen JH, et al. Presence and molecular epidemiology of virulence factors in methicillin-resistant Staphylococcus aureus strains colonizing and infecting soldiers. J Clin Microbiol. 2009;47(4):940–945.
- Safdar N, Bradley EA. The risk of infection after nasal colonization with Staphylococcus aureus. Am J Med. 2008;121(4):310–315.
- Kim MW, Greenfield BK, Snyder RE, et al. The association between community-associated Staphylococcus aureus colonization and disease: a meta-analysis. BMC Infect Dis. 2018;18(1):86.
- Hart J, Hamilton EJ, Makepeace A, et al. Prevalence, risk factors and sequelae of Staphylococcus aureus carriage in diabetes: the Fremantle Diabetes Study Phase II. J Diabetes Complications. 2015;29(8):1092–1097.
- Clinical and Laboratory Standards Institute. M100-S26. Performance standards for antimicrobial susceptibility testing: 26th informational supplement. Wayne (PA): Clinical and Laboratory Standards Institute; 2016.